A PARG Inhibitor DAT-2645 Monotherapy in Patients with Advanced/Metastatic Solid Tumors Harboring BRCA1/2 Loss of Function Alterations And/or Other Defects in the DDR Pathway
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Related studies linked through entity extraction aliases.